NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 3 filers reported holding NEWLINK GENETICS CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $29,000 | +61.1% | 10,700 | 0.0% | 0.00% | – |
| Q3 2019 | $18,000 | +28.6% | 10,700 | 0.0% | 0.00% | – |
| Q2 2019 | $14,000 | -33.3% | 10,700 | 0.0% | 0.00% | – |
| Q1 2019 | $21,000 | +31.2% | 10,700 | 0.0% | 0.00% | – |
| Q4 2018 | $16,000 | -65.2% | 10,700 | -44.3% | 0.00% | -100.0% |
| Q3 2018 | $46,000 | -88.6% | 19,200 | -77.4% | 0.00% | -83.3% |
| Q2 2018 | $404,000 | -49.6% | 84,932 | -23.2% | 0.01% | -68.4% |
| Q1 2018 | $802,000 | -13.3% | 110,624 | -3.0% | 0.02% | -5.0% |
| Q4 2017 | $925,000 | -32.7% | 114,002 | -15.6% | 0.02% | -37.5% |
| Q3 2017 | $1,375,000 | +25.3% | 135,080 | -9.5% | 0.03% | +23.1% |
| Q2 2017 | $1,097,000 | -77.4% | 149,272 | -25.9% | 0.03% | -77.8% |
| Q1 2017 | $4,857,000 | +131.9% | 201,532 | -1.1% | 0.12% | +120.8% |
| Q4 2016 | $2,094,000 | -44.9% | 203,732 | -19.5% | 0.05% | -45.9% |
| Q3 2016 | $3,801,000 | +31.8% | 253,032 | -1.2% | 0.10% | +28.9% |
| Q2 2016 | $2,883,000 | -43.3% | 256,082 | -8.4% | 0.08% | -39.7% |
| Q1 2016 | $5,087,000 | -44.0% | 279,532 | +11.9% | 0.13% | -42.2% |
| Q4 2015 | $9,088,000 | +3.0% | 249,732 | +1.4% | 0.22% | +1.4% |
| Q3 2015 | $8,825,000 | -21.1% | 246,222 | -2.5% | 0.22% | -14.0% |
| Q2 2015 | $11,182,000 | -20.2% | 252,590 | -1.4% | 0.25% | -20.6% |
| Q1 2015 | $14,013,000 | +38.4% | 256,140 | +0.5% | 0.32% | +37.6% |
| Q4 2014 | $10,128,000 | +125.6% | 254,790 | +21.5% | 0.23% | +120.2% |
| Q3 2014 | $4,490,000 | -19.2% | 209,640 | +0.2% | 0.10% | -21.2% |
| Q2 2014 | $5,557,000 | -56.7% | 209,290 | -53.7% | 0.13% | -14.3% |
| Q1 2014 | $12,846,000 | +44.3% | 452,316 | +11.8% | 0.15% | +46.7% |
| Q4 2013 | $8,904,000 | +134.4% | 404,552 | +100.0% | 0.10% | +11.7% |
| Q3 2013 | $3,799,000 | -4.3% | 202,276 | +0.5% | 0.09% | -10.5% |
| Q2 2013 | $3,969,000 | +60.9% | 201,276 | +0.1% | 0.10% | +59.1% |
| Q1 2013 | $2,467,000 | – | 201,026 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |